Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG rallies as RBC hails long-term growth prospects

Tue, 15th Dec 2015 13:58

(ShareCast News) - RBC Capital Markets initiated coverage of specialist pharmaceutical company BTG at 'outperform' with a price target of 820p, saying it should be a long-term holding.It said the shares have underperformed materially over the past year and, while medium-term market expectations are still ambitious, the potential near-term approval of RePneu in the US and BTG's long-term growth prospects are fundamental reasons to own the stock.RBC said the stock weakness has been almost entirely associated with the weak launch of the company's varicose vein product, Varithena, but now presents an opportunity as the factors behind the selloff are being resolved and are short term."Given the advantages of this product over current technologies, we continue to believe Varithena could exceed management's $500m revenue target," it said.RBC said BTG's RePneu - a memory coil for emphysema which could provide another option for patients on top of pharmaceuticals and an alternative to lung volume reduction surgery - is also critical and overlooked."With management still planning to submit RePneu for FDA approval in 2016, we remain optimistic for approval by end-2016, which should lead to a material re-rating."At 1403 GMT, BTG shares were up 6.6% to 664.50p.
More News
8 Jun 2016 13:18

Wednesday broker round-up

(ShareCast News) - Hochschild Mining: UBS downgrades to neutral with a target price of 160p. Esure Group: JP Morgan keeps at overweight with a 330p target. Royal Dutch Shell: RBC reiterates outperform with a target price of 2000p and JP Morgan stays atneutral with a target price of 1630p. National

Read more
19 May 2016 08:30

BROKER RATINGS SUMMARY: Goldman Sachs Upgrades BT To Conviction Buy

Read more
18 May 2016 08:31

BROKER RATINGS SUMMARY: Goldman Upgrades Booker, Panmure Cuts Meggitt

Read more
17 May 2016 09:40

WINNERS & LOSERS SUMMARY: Taylor Wimpey Pleases With Payout Plan

Read more
17 May 2016 07:56

Revenue jump boosts BTG full-year profits

(ShareCast News) - Healthcare company BTG more than doubled full year pre-tax profits to £57.5m on the back of a 22% jump in revenues to £447.5m. The company said expected revenue for fiscal 2017 to be in the range of £485m-£515m, with selling general and administrative costs to be £160m-£170m and r

Read more
17 May 2016 06:57

TOP NEWS: BTG Doubles Annual Profit On Significant Revenue Rise

Read more
10 May 2016 15:10

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2016 09:23

BTG buys Galil Medical for inital £58.3

(ShareCast News) - Specialist healthcare company BTG said it was buying Galil Medical, a leading provider of cryoablation products for the treatment and palliative care of kidney and other cancers, for an initial £58.3m. BTG said it would also pay up to £17.6m in future regulatory and commercial mil

Read more
6 May 2016 08:10

BTG Acquires US-Based Cryoablation Systems Maker Galil Medical

Read more
5 Apr 2016 07:41

BTG exudes confidence ahead of final reuslts

(ShareCast News) - Specialist healthcare company BTG was confident ahead of its final results on Tuesday, claiming reported group revenue for the year to 31 March was expected to be at the upper end of its guidance range of £410m-£440m, boosted by currency tailwinds. The growth at the FTSE 250 compa

Read more
5 Apr 2016 06:39

BTG Revenue To Hit Upper End Of Guidance Amid Solid Sales Growth

Read more
4 Apr 2016 05:23

BTG To Initiate Target Study To Evaluate Dosimetry For HCC Patients

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
15 Dec 2015 17:05

LONDON MARKET CLOSE: Oil Recovers As US Inflation Supports Fed Hike

Read more
15 Dec 2015 15:24

FTSE 250 movers: Broker notes spur on big movers

(ShareCast News) - The FTSE 250 looks to finish the day in the green, with the second-tier market up 228.85 point (1.36%) to 17,001.42 mid-afternoon Tuesday. Circassia Pharmaceuticals rose to the top of the ranks after RBC Capital Markets initiated coverage at 'top pick' for the company. "With intr

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.